Showing results (141-150 of 357) with videos related to
Sort By:
Pageof 36
Endocrinology, Diabetes & Metabolism Case Reports|March 27, 2018
Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditisPloutarchos Tzoulis, Richard W Corbett, Swarupini Ponnampalam, et al.Clinical Lymphoma & Myeloma|June 16, 2009
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone diseaseEleftheria Hatzimichael, George Dranitsaris, Aggeliki Dasoula, et al.Antiviral Research|March 10, 2010
Clinical outcome in resistant HIV-2 infection treated with raltegravir and maravirocDarius Armstrong-James, Justin Stebbing, Andrew Scourfield, et al.Oncoimmunology|December 8, 2018
Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trialsQingyuan Huang, Hua Zhang, Josephine Hai, et al.Pharmaceutics|December 5, 2019
Thermosensitive Liposome-Mediated Drug Delivery in Chemotherapy: Mathematical Modelling for Spatio-temporal Drug Distribution and Model-Based OptimisationYu Huang, Boram Gu, Cong Liu, et al.Best Practice & Research. Clinical Endocrinology & Metabolism|August 26, 2015
Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and diseasePaul Cathcart, Walter Lucchesi, Silvia Ottaviani, et al.Breast Cancer Research and Treatment|June 13, 2015
Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysisRamya Ramaswami, Marcos Daniel Villarreal, Dina Marie Pitta, et al.Leukemia & Lymphoma|June 30, 2004
Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levelsTom Newsom-Davis, Mark Bower, Adrian Wildfire, et al.Cancer Medicine|October 14, 2022
A pyroptosis-related lncRNA signature in bladder cancerPeng Wang, Zhiqiang Wang, Liping Zhu, et al.AIDS (London, England)|July 11, 2003
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcomaSimon Portsmouth, Justin Stebbing, Jas Gill, et al.Pageof 36